Bruno Fattizzo Francesco Versino Anna Zaninoni Anna Paola Maria Luisa Marcello Cristina Vercellati Silvia Artuso Wilma Barcellini
10.3389/fimmu.2022.1060923
Front Immunol
2022 Dec 1;13:1060923.
direct antiglobulin test ektacytometry extravascular hemolysis paroxysmal nocturnal hemoglobinuria pegcetacoplan
CC BY
https://pubmed.ncbi.nlm.nih.gov/36532073/
Hemoglobinuria, Paroxysmal / drug therapy
Hemoglobinuria, Paroxysmal / drug therapy Case Reports Research Support, Non-U.S. Gov't Complement C3 Complement C5 Complement Inactivating Agents / therapeutic use Hemolysis Humans Quality of Life pegcetacoplan Complement C3 Complement Inactivating Agents Complement C5
PMC9751407
36532073
Case report: Transfusion independence and abolition of extravascular hemolysis in a PNH patient treated with pegcetacoplan
2022